TLPH Q3 2020 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q3 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1M+125.0% YoY

Gross Profit

-$483,000-35.3% margin

Operating Income

-$9M-660.6% margin

Net Income

-$9M-652.8% margin

EPS (Diluted)

$-2.03

QoQ Revenue Growth

-53.2%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$66M

Total Liabilities

$124M

Stockholders' Equity

-$58M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$608,000	+125.0%
Gross Profit	-$483,000	-$3M	+81.4%
Operating Income	-$9M	-$14M	+33.2%
Net Income	-$9M	-$13M	+29.9%